(Q30885471)

27 June 2017

title

Designing chiral libraries for drug discovery (English)

1 reference

27 June 2017

1 reference

1 reference

Beroza P

1

1 reference

27 June 2017

Suto MJ

series ordinal

2

1 reference

27 June 2017

publication date

1 August 2000

1 reference

27 June 2017

1 reference

27 June 2017

volume

5

1 reference

27 June 2017

issue

8

1 reference

27 June 2017

page(s)

364-372

1 reference

Microarrays: biotechnology's discovery platform for functional genomics.

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

Approaches to higher-throughput pharmacokinetics (HTPK) in drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

Genomics and the discovery of new drug targets

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

Proteomics: a major new technology for the drug discovery process

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

High-throughput and ultra-high-throughput screening: solution- and cell-based approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

Computational methods for the prediction of 'drug-likeness'

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

Pharmacokinetics and metabolism in early drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

Strategic Pooling of Compounds for High-Throughput Screening

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

Computational approaches for combinatorial library design and molecular diversity analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

Advances in diversity profiling and combinatorial series design

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

Chiral drugs: synopsis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

Stereoisomers and drug toxicity. The value of single stereoisomer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

Stereoselective allosteric binding interaction on human serum albumin between ibuprofen and lorazepam acetate

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

Pharmacophore fingerprinting. 1. Application to QSAR and focused library design

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901515-4

7 January 2021

10.1016/S1359-6446(00)01515-4

Identifiers

DOI

1 reference

27 June 2017

1 reference